BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36277720)

  • 1. Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.
    Tseng CH
    Front Endocrinol (Lausanne); 2022; 13():1036885. PubMed ID: 36277720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
    Tseng CH
    BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin.
    Tseng CH
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
    Tseng CH
    J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study.
    Tseng CH
    Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1389-1400. PubMed ID: 36939574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin reduces risk of varicose veins in patients with type 2 diabetes.
    Tseng CH
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3206. PubMed ID: 31322821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
    Tseng CH
    Front Med (Lausanne); 2020; 7():592901. PubMed ID: 33693008
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Front Pharmacol; 2020; 11():578831. PubMed ID: 33664665
    [No Abstract]   [Full Text] [Related]  

  • 15. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
    Tseng CH
    Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Tseng CH
    Eur J Endocrinol; 2019 Jun; 180(6):365-372. PubMed ID: 30986765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus.
    Tseng CH
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29954747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.